top of page

Dementia

Videos

Blog Posts

Research Articles

Alzheimer's and CBD

Cory Rice, D.O.

Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes

El-Remessy, A. B., Al-Shabrawey, M., Khalifa, Y., Tsai, N.-T., Caldwell, R. B., & Liou, G. I.

The American Journal of Pathology

Jan 1, 2006

A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study

Jadoon, K. A., Tan, G. D., & O’Sullivan, S. E.

JCI Insight

Jun 15, 2017

Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study

Jadoon, K. A., Ratcliffe, S. H., Barrett, D. A., Thomas, E. L., Stott, C., Bell, J. D., O'Sullivan, S. E., Tan, G.

Diabetes Care

Oct 1, 2016

Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes

El-Remessy, A. B., Al-Shabrawey, M., Khalifa, Y., Tsai, N.-T., Caldwell, R. B., & Liou, G. I.

The American Journal of Pathology

Sep 6, 2005

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease

Watt, G., & Karl, T.

Frontiers in Pharmacology

Feb 3, 2017

Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy

Abate G, Uberti D, Tambaro S.

Biology

Jun 17, 2021

Prescription of a THC/CBD-Based Medication to Patients with Dementia: A Pilot Study in Geneva

Broers, B., Patà, Z., Mina, A., Wampfler, J., de Saussure, C., & Pautex, S.

Medical Cannabis and Cannabinoids

Apr 4, 2019

Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids

Currais, A., Quehenberger, O., M Armando, A., Daugherty, D., Maher, P., & Schubert, D.

npj Aging and Mechanisms of Disease

Jun 23, 2016

Title

Author

Journal

Date

bottom of page